The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Myotonic Dystrophy: EPIC Functions at The Ottawa Hospital

In 2019, the Ottawa Hospital (TOH) introduced a new Electronic Health Record system called EPIC, to move documentation such as orders for blood work, prescriptions, notes and letters from paper-based to online digital formats. This involved a major investment in education and training of hospital staff.

 

A recent initiative highlights how EPIC functions can be tailored to improve the safety of patients with a rare muscle condition called myotonic dystrophy (DM). DM is a genetic condition that leads to muscle weakness and wasting, and to additional health issues such as cardiac arrhythmia, cataracts of the eyes, diabetes, constipation, and disrupted sleep. DM patients also respond with severe side effects to a range of medications and anaesthetics.

 

At the Neuromuscular Centre at TOH there are more than 50 patients with DM under the care of neuromuscular specialists, who aware of the specific risks and health issues associated with DM. However, DM patients frequently need to seek medical attention at other TOH departments, whose staff may not be aware of the DM diagnosis or the specific risks associated with prescriptions.

 

Inspired by a DM family from Ottawa, the TOH medical information team has designed a new EPIC functionality, so-called Best Practice Advisories (BPA), to keep DM patients safe throughout the hospital. Firstly, a side panel alert informs doctors and nurses accessing the patient’s records about the DM diagnosis and provides guidance through a specific “standards of care” document that has been devised by international experts together with the Myotonic Dystrophy Foundation. Secondly, a specific warning will be displayed if the doctor attempts to order a medication that is considered potentially unsafe for DM; to proceed with the order, they are required to acknowledge the warning and explain their reasons.

 

The new BPAs went live in June 2021. If successful, they may be adopted by other hospitals and organisations in Canada to keep DM patients safe.

 

The Neuromuscular Disease Network for Canada (NMD4C) is a network of clinicians, scientists, patients and patient advocacy groups, committed to improving the care, research, and treatment of neuromuscular diseases for all Canadians. The network is encouraged to see projects such as this that engage multiple stakeholders, identifying and addressing issues from different perspectives and fostering collaborations that deliver impactful outcomes.

 

For further information please contact:

James Davis, NMD4C Communications Coordinator

EPIC_DM

Read next...

Fellowship_Clinical_FB

NMD4C, MDC and CSCN to Launch Clinical Fellowship Funding Competition

The Neuromuscular Disease Network for Canada (NMD4C) together with Muscular Dystrophy Canada (MDC) and the Canadian Society of Clinical Neurophysiologists (CSCN) are excited to announce the launch of a funding competition to award three new national clinical fellowship awards in neuromuscular medicine and electromyography!

new WG members

Early-Career Members Join NMD4C Working Groups

The NMD4C is happy to announce that six early-career network members have been appointed to leadership roles on three NMD4C working groups: Biobanking, Clinical and Translational Empowerment of Early-Career Members, and Knowledge Translation. 

Neuromuscular Awareness September

Neuromuscular Awareness Events September Roundup

September is a busy month for neuromuscular disease awareness, as the month contains several awareness days as well as month-long campaigns. Take a moment to read about the different events that took place during September, and how different organizations and individuals raised awareness, educated, and took action for these different NMDs.

Natl PD Appreciation week (1)

National Postdoc Appreciation Week September 20-24, 2021

September 20-24 is National Postdoc Appreciation Week, and the NMD4C would like to take this time to recognize and celebrate the contributions of our postdoctoral members to the neuromuscular community. The scientific achievements, research, and discoveries from postdoctoral fellows advances our understanding of neuromuscular diseases.

CIHR logo

CIHR Grant Funding for BIND Study: Assessing the Indirect Socio-Economic Burden of Inherited Neuromuscular Diseases

The NMD4C is happy to share that a project application featuring many NMD4C members on Assessing the Indirect Socio-Economic Burden of Inherited Neuromuscular Diseases has been awarded a Canadian Institute…

DDCC 2021 - E-Blast Banner FINAL UPDATED

Session Two of Defeat Duchenne Canadian Conference Addressing Standards of Care in Canada this Weekend

September 7th is World Duchenne Awareness Day. Over the past decades, life expectancy of individuals affected by Duchenne muscular dystrophy (DMD) has increased significantly, and adults with DMD are not…